AceMapAI

AceMapAI (Suzhou) Life Science & Technology Co., Ltd. (referred to as AceMapAI) was established in October 2021. It is professionally engaged in AI-driven new drug research and development, committed to leveraging world-leading artificial intelligence technologies to advance the development of new drugs for the benefit of human health. The company gathers scientific research talents from top universities and research institutions both within and outside China, as well as a professional team with years of experience in well-known pharmaceutical enterprises around the globe. Relying on cutting-edge artificial intelligence technology and integrating engineering chemistry, computational chemistry, computational biology, and cloud computing, the company serves various processes of drug research and development. Currently, the artificial intelligence drug discovery platform being developed by the company can help drug researchers significantly save time and costs in the drug development process.Adhering to the business philosophy of prioritizing customers, honoring service, respecting creativity, and emphasizing technology, the company upholds the corporate spirit of cooperation, sharing, and win-win outcomes. It follows the talent concept of recognizing people's strengths and making full use of their abilities. Through the implementation of strategies such as open innovation, excellent operation management, and human resource development, the company sincerely provides professional and high-quality services to its customers, builds core competitiveness, establishes a professional industry brand, and delivers valuable industry services.